Found 175 matching trials
OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time NA Monotherapy with a P2Y12 inhibitor after a minimum period of DAPT following...
Show More Location
General Hospital of Northern Theater Command
Learn More & Join Trial
Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy NA The study aims to evaluate a modified antiplatelet therapy associated with ...
Show More Location
Universitätsklinikum
Learn More & Join Trial
XIENCE 28 USA Study NA The XIENCE 28 USA Study is prospective, single arm, multi-center, open labe...
Show More Location
Heart Center Research, LLC
Learn More & Join Trial
Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS PHASE4 A prospective, randomised, open label study of 3 clinically licensed treatm...
Show More Location
East and North Hertfordshire NHS Trust
Learn More & Join Trial
Future Optimal Research and Care Evaluation N/A Rationale: Acute coronary syndrome (ACS) is the leading cause of death worl...
Show More Location
Gelre Ziekenhuizem
Learn More & Join Trial
Short-term Dual Antiplatelet Therapy After Deployment of Bioabsorbable Polymer Everolimus-eluting Stent NA To compare the clinical outcomes of P2Y12 antagonist monotherapy with aspir...
Show More Location
Gangnam Severance Hospital
Learn More & Join Trial
Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry N/A The purpose of this observational registry was to compare the safety and ef...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events PHASE4 EDUCATE is a prospective, multi-center study designed to collect real-world...
Show More Location
AnMed Health Medical Center
Learn More & Join Trial
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) PHASE4 This study is a prospective, multicenter, parallel, open-label, randomized,...
Show More Location
Xinqiao Hospital, Army Medical University
Learn More & Join Trial
A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY) PHASE4 In patients with heart attacks, the current standard of care is to restore ...
Show More Location
University of Ottawa Heart Institute
Learn More & Join Trial